Medicamen Biotech Live Share Price Today, Share Analysis and Chart

Name: Medicamen Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Medicamen Biotech Ltd.
Rating: 2.164541625
Author: Trendlyne DVM scores

Slowing Down Stock

Iran war impact

The impact of the Iran-Israel war on Medicamen Biotech Ltd. is currently assessed as Neutral to marginally Negative, primarily due to the company's limited direct exposure to the conflicting nations and its strategic focus on shifting towards...

286.60 -4.60 (-1.58%)

New 52W Low today

16,406

NSE+BSE Volume

NSE 09 Mar, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Bearish

29.3 / 100

Slowing Down Stock These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest View Similar Embed DVM

No estimates available

Medicamen Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%

Medicamen Biotech Live Share Price Today, Share Analysis and Chart

The impact of the Iran-Israel war on Medicamen Biotech Ltd. is currently assessed as Neutral to marginally Negative, primarily due to the company's limited direct exposure to the conflicting nations and its strategic focus on shifting towards...

New 52W Low today

SWOT Analysis

Medicamen Biotech Live Price Chart